Content area

|
|

Succesfuld behandling af akut promyelocytleukæmi uden brug af kemoterapi og blodtransfusion

Forfatter(e)
Michael Tøstesen, Lene S.G. Østgård, Eigil Kjeldsen, Jesper Stentoft & Jan M. Nørgaard Hæmatologisk Afdeling, Aarhus Universitetshospital Ugeskr Læger 2018;180:V06170489
Reference: 
Ugeskr Læger 2018;180:V06170489
Blad nummer: 
Sidetal: 
2-3
Successful treatment of acute promyelocytic leukaemia without chemotherapy and blood transfusion
Untreated acute promyelocytic leukaemia (APL) is a rapidly lethal blood cancer. Conventional treatment consists of all-trans retinoic acid and chemotherapy. Standard chemo­therapy-containing treatments necessitate the use of blood products. This is a case report of typical APL in a 32-year-old female patient, who due to religious conviction refused supportive therapy with blood products. A treatment regimen consisting of all-trans retinoic acid and arsenic trioxide was successful without the use of blood transfusions.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Per E. Holstein | 17/12
7 kommentarer
af Elo Aagaard Rasmussen | 17/12
19 kommentarer
af Hanne Hermann | 17/12
1 Kommentar
af Mette Holland-Fischer | 17/12
1 Kommentar
af Erik Sloth | 17/12
8 kommentarer
af Frank Thor Jørgensen | 16/12
2 kommentarer
af Trine Cecilie Jeppesen | 15/12
1 Kommentar
af Lars Linnet | 14/12
1 Kommentar